The Brighterside of News on MSN
New antibody restores immune system to fight pancreatic cancer
Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, ...
Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...
News-Medical.Net on MSN
Johns Hopkins study links mild pancreatic duct dilatation to higher cancer risk
Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...
This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...
HealthDay on MSN
Main Pancreatic Duct Dilation Increases Odds for Neoplastic Progression in High-Risk Individuals
Main pancreatic duct (MPD) dilation without an apparent obstructing lesion is an independent risk factor for neoplastic ...
Please provide your email address to receive an email when new articles are posted on . An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated ...
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
Ductal adenocarcinoma of the prostate is a rare, yet aggressive, subtype of prostate cancer that diverges in clinicopathological and genomic characteristics from the more common acinar adenocarcinoma.
Dr. Melvin Silverstein answers the question: 'What's Invasive Ductal Carcinoma?' — -- Question: What is invasive ductal carcinoma? Answer: Invasive ductal carcinoma is the most common type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback